Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Death rates from breast cancer are falling faster in Britain than in any of the other six most populous countries in Europe, according to research...
AstraZeneca has lifted the curtain on new Phase 3 data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin),...
A shortage of cancer doctors is putting patients at risk, according to a new report from the Royal College of Radiologists (RCR).
Allergan has revealed that Avycaz (ceftazidime and avibactam) has been awarded an expansion of its label by the FDA to include the treatment of...
Japanese firm Daiichi Sankyo has announced positive results of the first randomised controlled trial of uninterrupted Lixiana (edoxoban) in atrial...
- 23andMe to offer genetic reports on diabetes - Dutch pharmacists to circumvent Novartis cancer drug market exclusivity - New class of drugs offer...
Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ in the role, citing “personal...
Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of the...
The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to pharmaceutical industry...
The FDA has approved a new generic version of blood pressure drug valsartan. The approval comes amid shortages in supply after recalls were made in...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches